SENIOR ANALYST GL CLOSING AND REPORTING (CONTRATO POR 1 AÑO)

40.000.000 - 80.000.000


time left to apply End Date: May 3, 2025 (27 days left to apply) job requisition id R2793308 Senior Analyst GL Closing and Reporting About the job Our Hubs are a crucial part of how we innovate, improving performance across every Sanofi department and providing a springboard for the amazing work we do. Build a career and you can be part of transforming our business while helping to change millions of lives. Ready? As Senior Analyst GL Closing and Reporting within our A2R Team, you’ll deliver GL monthly closing & reporting services to SBS USA. Main responsibilities: Deliver GL monthly closing & reporting services Prepare management, tax, legal and statutory reporting at Group and country levels Address operational issues and follow through to resolution in an effective and timely manner Deliver operational KPIs and comply with Sanofi policies and guidelines Participate in continuous improvement initiatives About you Experience : Hands on expertise in GL accounting, closing & reporting processes and activities Soft and technical skills : Ability to interact with internal and external clients, team player and knowledge of IFRS Languages : Advanced English level Why choose us? Discover endless opportunities to grow your talent and drive your career, whether it’s through a promotion or lateral move, at home or internationally. You’ll be part of leading the first experiences a job seeker has with Sanofi and ensuring it is best-in-class and driving conversions. You’ll be part of a truly diverse cross-cultural team and can have real business impact. Flexible working policies, including up to 50% remote work. Private medical care, life and health insurance, and gender-neutral paid parental leave. At Sanofi, we provide equal opportunities to all regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, or gender identity. #J-18808-Ljbffr

trabajosonline.net © 2017–2021
Más información